Follow us_

Publication Search Results

Exact matches for:

• Author = Scolyer RA

1. Mao Y, Gide TN, Adegoke NA, Quek C, Maher N, Potter A, Patrick E, Saw RM, Thompson JF, Spillane AJ, Shannon KF, Carlino MS, Lo SN, Menzies AM, da Silva IP, Long GV, Scolyer RA, Wilmott JS
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, Camelia Quek, Nigel Maher, Alison Potter, Ellis Patrick, Robyn M Saw, John F Thompson, Andrew J Spillane, Kerwin F Shannon, Matteo S Carlino, Serigne N Lo, Alexander M Menzies, Inês Pires da Silva, Georgina V Long, Richard A Scolyer and James S Wilmott: Cross‑platform comparison of immune signatures in immunotherapy‑treated patients with advanced melanoma using a rank‑based scoring approach, Journal of Translational Medicine, 21 (2023), 257 (16 pages).

2. Wang KYX, Pupo GM, Tembe V, Patrick E, Strbenac D, Schramm SJ, Thompson JF, Scolyer RA, Muller S, Tarr G, Mann GJ, Yang YH
Kevin Y X Wang, Gulietta M Pupo, Varsha Tembe, Ellis Patrick, Dario Strbenac, Sarah-Jane Schramm, John F Thompson, Richard A Scolyer, Samuel Muller, Garth Tarr, Graham J Mann and Jean Y H Yang: Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine, npj Digital Medicine, 5 (open Access) (2022), no. 1, Article 85.

3. Wang KYX, Menzies AM, Silva IP, Wilmott JS, Yan Y, Wongchenko M, Kefford RF, Scolyer RA, Long GV, Tarr G, Muller S, Yang YH
Kevin YX Wang, Alexander M Menzies, Ines P Silva, James S Wilmott, Yibing Yan, Matthew Wongchenko, Richard F Kefford, Richard A Scolyer, Georgina V Long, Garth Tarr, Samuel Mueller and Jean YH Yang: bcGST – an interactive bias-correction method to identify over-represented gene-sets in boutique arrays, Bioinformatics, 35 (2019), no. 8, 1350–1357.

4. Hong AM, Ferguson P, Dodds T, Jones D, Li M, Yang YH, Scolyer RA
Angela M Hong, Peter Ferguson, Tristan Dodds, Deanna Jones, Mengbo Li, Jean Yang, Richard A Scolyer: Significant association of PD-L1 expression with human papillomaviruspositivity and its prognostic impact in oropharyngeal cancer, Oral Oncology, 92 (2019), 33–39.

5. Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang YH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H
Su Y Lim, Jenny H Lee, Tuba N Gide, Alexander M Menzies, Alexander Guminski, Matteo S Carlino, Edmond J Breen, Jean Y H Yang, Shila Ghazanfar, Richard F Kefford, Richard A Scolyer, Georgina V Long and Helen Rizos: Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1–based immunotherapy, Clinical Cancer Research, 25 (2019), no. 5, 1557–1563.

6. da Silva IP, Wang KYX, Wilmott JS, Holst J, Carlino MS, Park JJ, Quek C, Wongchenko M, Yan Y, Mann G, Johnson DB, Quade JLM, Rai R, Kefford RF, Rizos H, Scolyer RA, Yang YH, Long GV, Menzies AM
Inês Pires da Silva, Kevin Y.X. Wang, James S. Wilmott, Jeff Holst, Matteo S. Carlino, John J. Park, Camelia Quek, Matthew Wongchenko, Yibing Yan, Graham Mann, Douglas B. Johnson, Jennifer L. McQuade, Rajat Rai, Richard F. Kefford, Helen Rizos, Richard A. Scolyer, Jean Y.H. Yang, Georgina V. Long and Alexander M. Menzies: Distinct molecular profiles and immunotherapy treatment outcomes of V600E and V600K BRAF-mutant melanoma, Clinical Cancer Research, 25 (2019), no. 4, 1272–1279.

7. Lim SY, Lee JH, Gide TN, Menzies AM, Guminski A, Carlino MS, Breen EJ, Yang YH, Ghazanfar S, Kefford RF, Scolyer RA, Long GV, Rizos H
Su Y Lim, Jenny H Lee, Tuba N Gide, Alexander M Menzies, Alexander Guminski, Matteo S Carlino, Edmond J Breen, Jean YH Yang, Shila Ghazanfar, Richard F Kefford, Richard A Scolyer, Georgina V Long, Helen Rizos: Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-PD-1-based immunotherapy, Clinical Cancer Research, 1 (2018), 2795.2018.

8. Sykes EK, McDonald CE, Ghazanfar S, Mactier S, Thompson JF, Scolyer RA, Yang YH, Mann GJ, Christopherson RI
Erin K Sykes, Cassandra E McDonald, Shila Ghazanfar, Swetlana Mactier, John F Thompson, Richard A Scolyer, Jean Y Yang, Graham J Mann, Richard I Christopherson: A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma, PROTEOMICS–Clinical Applications, 12 (2018), no. 3, 1700094.

9. Patrick E, Schramm S-J, Ormerod JT, Scolyer RA, Mann GJ, Muller S, Yang YH
E Patrick, S-J Schramm, JT Ormerod, RA Scolyer, GJ Mann, S Mueller, YH Yang: A multi-step classifier addressing cohort heterogeneity improves performance of prognostic biomarkers in three cancer types, Oncotarget, 8 (2017), no. 2, 2807–2815.

10. Madore J, Strbenac D, Vilain R, Menzies AM, Yang YH, Thompson JF, Long GV, Mann GJ, Scolyer RA, Wilmott JS
Jason Madore, Dario Strbenac, Ricardo Vilain, Alexander M Menzies, Jean Y H Yang, John F Thompson, Georgina V Long, Graham J Mann, Richard A Scolyer, and James SWilmott: PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma, Clinical Cancer Research, 22 (2016), no. 15, 3915–3923.

11. Jayawardana K, Schramm SJ, Tembe V, Muller S, Thompson JF, Scolyer RA, Mann GJ, Yang YH
K Jayawardana, S-J Schramm, V Tembe, S Mueller, JF Thompson, RA Scolyer, GJ Mann, J Yang: Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma, Journal of Investigative Dermatology, 136 (2016), 245–254.

12. Jayawardana K, Schramm SJ, Haydu L, Thompson JF, Scolyer RA, Mann GJ, Muller S, Yang YH
Kaushala Jayawardana, Sarah-Jane Schramm, Lauren Haydu, John F Thompson, Richard A Scolyer, Graham J Mann, Samuel Müller and Jean Yee Hwa Yang: Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information, International Journal of Cancer, 136 (2015), no. 4, 863–874.

13. Mactier S, Kaufman KL, Wang P, Crossett B, Pupo GM, Kohnke PL, Thompson JF, Scolyer RA, Yang YH, Mann GJ, Christopherson RI
Swetlana Mactier, Kimberley L Kaufman, Penghao Wang, Ben Crossett, Gulietta M Pupo, Philippa L Kohnke, John F Thompson, Richard A Scolyer, Jean Y Yang, Graham J Mann and Richard I Christopherson: Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients, Pigment Cell and Melanoma Research, 27 (2014), no. 6, 1106–1116.

14. Kaufman KL, Mactier S, Armstrong NJ, Mallawaaratchy D, Byrne S, Haydu L, Jakrot V, Thompson JF, Mann GJ, Scolyer RA, Christopherson. RI
K.L. Kaufman, S. Mactier, N.J. Armstrong, D. Mallawaaratchy, S. Byrne, L. Haydu, V. Jakrot, J.F. Thompson, G.J. Mann, R.A. Scolyer, R.I. Christopherson.: Surface antigen profiles of leukocytes and melanoma cells in lymph nodes correlate with survival in AJCC stage III metastatic melanoma patients., Clinical and Experimental Metastasis, 31 (2014), no. 4, 407–421.

15. Schramm SJ, Li SS, Jayaswal V, Fung DCY, Campain AE, Pang CNI, Scolyer RA, Yang YH, Mann GJ, Wilkins MR
S J Schramm, S S Li, V Jayaswal, D C Y Fung, A E Campain, C N I Pang, R A Scolyer, Y H Yang, G J Mann, M R Wilkins: Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden, Pigment Cell and Melanoma Research, 26 (2013), no. 5, 708–722.

16. Mann GJ, Pupo GM, Campain AE, Carter CD, Schramm SJ, Pianova S, Gerega SK, De Silva C, Lai K, Wilmott JS, Synnott M, Hersey P, Kefford RF, Thompson JF, Yang YH, Scolyer RA
Graham J Mann, Gulietta M Pupo, Anna E Campain, Candace D Carter, Sarah-Jane Schramm, Svetlana Pianova, Sebastien K Gerega, Chitra De Silva, Kenneth Lai, James S Wilmott, Maria Synnott, Peter Hersey, Richard F Kefford, John F Thompson, Yee Hwa Yang and Richard A Scolyer: BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma, Journal of Investigative Dermatology, 133 (2013), 509–517.

17. Schramm SJ, Campain AE, Scolyer RA, Yang YH, Mann GJ
Sarah-Jane Schramm, Anna E Campain, Richard A Scolyer, Yee Hwa Yang and Graham J Mann: Review and cross-validation of gene expression signatures and melanoma prognosis, Journal of Investigative Dermatology, 132 (2012), 274–283.

18. Karim RZ, Gerega SK, Yang YH, Spillane AJ, Carmalt H, Scolyer RA, Lee CS
Rooshdiya Z Karim, Sebastien K Gerega, Y H Yang, Andrew Spillane, Hugh Carmalt, Richard A Scolyer& C Soon Lee: p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours, Histopathology, 56 (2010), 868–875.

19. Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA
Karim RZ, Li W, Sanki A, Colman MH, Yang YH, Thompson JF, Scolyer RA: Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors., International Journal of Surgical Pathology, 17 (2009), no. 5, 361–367.

20. Karim RZ, Gerega SK, Yang YH, Spillane AJ, Carmalt H, Scolyer RA, Lee CS
Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, Lee CS: Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution., Breast, 18 (2009), no. 3, 165–170.